Faye Sharpley
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 18, 2021
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.Faye A Sharpley, Richa Manwani, Aviva Petrie
|Dec 16, 2020
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).Faye A Sharpley, Jemma Larham, Angus Haines
|Dec 10, 2019
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.Faye A Sharpley, Dunnya De-Silva, Shameem Mahmood
|Aug 15, 2019
A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.Faye A Sharpley, Aviva Petrie, Shameem Mahmood
|Aug 08, 2019
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham
|Jul 24, 2019
Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era.F A Sharpley, P Neffa, F Panitsas
Pageof 2
